Navigation Links
Researchers undertake radical new cancer survivorship study
Date:5/17/2012

Researchers from the Macmillan Survivorship Research Group (MSRG), at the University of Southampton, have developed the first study of its kind looking at the experiences and needs of people after primary treatment of colorectal cancer.

It is estimated that around two million people are living with, or beyond, cancer in the UK, with this figure rising by 3% each year. On average over 6,000 patients are diagnosed with cancer each year in Hampshire alone.

Whilst increasing cancer survival rates are to be celebrated, the experiences and needs of those who have completed their treatment have been relatively neglected until now.

The University of Southampton, which celebrates its 60th anniversary this year, has a long standing history of cancer research. It has developed the ColoREctal Wellbeing (CREW) study to look at a number of factors influencing recovery which takes into account the disease itself, the level of treatment patients receive, the support available to them and the range of coping skills they have.

Factors influencing recovery studied within the research include the time it takes a patient to return to feeling 'well', the length of time symptoms of treatment last and the range of things people can do to help return to 'normal' more quickly.

Results from this rigorous theory-informed study will, for the first time, inform health care providers and professionals across the country about what helps or hinders rapid and effective recovery and who has the confidence and ability to manage their own problems. It will also help identify areas for the development of interventions to aid the recovery process of those who may be at risk of experiencing problems.

More than 1,000 patients have been recruited to the study, one of whom is Susan Restorick-Banks from Totton in Hampshire.

Susan was diagnosed with a tumour in her colon in early 2011. She has endured Radiotherapy, surgery to remove the tumour and six months of chemotherapy. She says: "It's been really important for me to participate in this study. By speaking out and giving my views, I feel I'm contributing to the wellbeing of future cancer survivors and it's really the only way researchers have of finding out how people like me cope.

"Whilst I've had a very supportive network around me, and have continued to enjoy life throughout my treatment, I know that other people going through cancer treatment can experience things very differently."

Colorectal cancer has been chosen as the focus for the study as it is one of the most treatable cancers in the UK. It affects both men and women equally and can involve all three forms of basic cancer treatment: surgery, chemotherapy and radiotherapy.

The participants, 187 of whom are from Southampton, will be followed over a two-year period establishing the natural history of the recovery of their health and wellbeing and assessing how quickly they recover after colorectal cancer.

Senior Research Fellow at the University of Southampton and chief investigator for the research Dr Deborah Fenlon says: "Up until now the general focus for cancer research has been on cure and prevention for the disease. Macmillan is uniquely concerned with helping to improve the lives of people living with cancer, and for us it is absolutely imperative we understand the experiences of the two million cancer survivors in order to positively inform the professionals who interact and support these survivors, helping them get the best out of life once treatment is over."

Professor Jessica Corner, Dean of Health Sciences at the University of Southampton and Chief Clinician of Macmillan, says, "As a leading health sciences research-based Faculty, and the only research unit funded by Macmillan, we are extremely proud to be undertaking this radical new research. Our ultimate joint-aim is to help improve the lives of people with cancer by informing health care providers and professionals in practice which help care for the two million plus cancer survivors across the UK. Recruiting more than 1000 patients is a real milestone for the study and we are incredibly grateful to Susan and all those participating and involved in the research."

This study forms part of a trio of research projects being undertaken by Health Sciences researchers from the MSRG. Initial research was conducted into how people manage cancer and cancer-related problems followed by creating and testing an online intervention to support self-management.

Ciarn Devane, Chief Executive of Macmillan Cancer Support, says: "We are delighted to congratulate our Macmillan Survivorship Research Group in their recruitment of their 1,000th research participant to the CREW research study. Macmillan is committed to understanding and using evidence, to help the 2 million people living with cancer in the UK. Work with our academic colleagues is helping us to increase our knowledge and will allow us to develop our services in the future.

"The CREW study is important in helping us learn more about bowel cancer patients and their different needs after treatment. The information gained through research will help us support and improve the lives of the increasing numbers of people who are living with and beyond cancer."


'/>"/>

Contact: Becky Attwood
r.attwood@soton.ac.uk
44-238-059-5457
University of Southampton
Source:Eurekalert

Related medicine news :

1. Researchers make promising discovery in pursuit of effective lymphoma treatments
2. Breast cancer effectively treated with chemical found in celery, parsley by MU researchers
3. New biomarker test predicts arthritis at much earlier stage, MU researchers say
4. Researchers Test Laxative-Free Colon Scan
5. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
6. Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
7. Researchers see BPA effects in monkey mammary glands
8. Geisel researchers sift through junk to find colorectal cancer clues
9. Email vacations decrease stress, increase concentration, researchers say
10. Researchers Rejuvenate Blood-Forming Stem Cells in Mice
11. CNIO researchers describe new functions of cohesin relevant for human disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: